FORMULA-509 probes salvage radiation and gonadotropin-releasing hormone routine

On this video, Paul Nguyen, MD, a genitourinary radiation oncologist at Dana-Farber Most cancers Institute, discusses the FORMULA-509 trial he co-presented at ASCO Genitourinary Cancers Symposium.

The learn about tested sufferers with a emerging PSA after radical prostatectomy who had no less than one negative chance issue, and who gained salvage radiation and six months of a gonadotropin-releasing hormone agonist.

“What I feel we will say now could be for a affected person lately, the usage of the FORMULA-509 routine is an excessively horny selection to having to elongate the length of hormone remedy to 24 months,” Nguyen mentioned.

Reference:

• Nguyen P, et al. FORMULA-509: A multicenter randomized trial of post-operative salvage radiotherapy (SRT) and six months of GnRH agonist without or with abiraterone acetate/prednisone (AAP) and apalutamide (Apa) post-radical prostatectomy (RP). Introduced at: ASCO Genitourinary Cancers Symposium; ; Feb. 16-18, 2023; San Francisco.

ADD TOPIC TO EMAIL ALERTS

Obtain an electronic mail when new articles are posted on

Please supply your electronic mail cope with to obtain an electronic mail when new articles are posted on .

” data-action=subscribe>
Subscribe

We have been not able to procedure your request. Please take a look at once more later. In the event you proceed to have this factor please touch [email protected].

Again to Healio

Take Properties in Prostate Most cancers